We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Highly Sensitive Thyroglobulin Chemiluminescent Microparticle Immunoassay Evaluated

By LabMedica International staff writers
Posted on 20 Jul 2022

Differentiated thyroid cancer (DTC) is the most frequent endocrine malignancy. More...

Standard treatment of DTC is thyroidectomy plus, for high risk cases, radioactive iodine ablation therapy, and pharmacological suppression of TSH.

Thyroglobulin (Tg) measurement is an essential diagnostic element of the follow-up and management of patients with differentiated thyroid cancer (DTC), as the 660 kDa glycoprotein is exclusively produced by benign or well-differentiated malignant thyroid cells. Tg is the matrix for synthesis and storage form of thyroxine (T4) and triiodothyronine (T3) within the thyroid follicles.

Clinical Biochemists at the University Health Network (UHN, Toronto, ON, Canada) participated in a three-center study, Tg values of 447 routine patient samples, characterized for the presence of anti-Tg. Mostly fresh samples from routine Tg requests were used. In addition, frozen samples, and precision and limit of quantitation patient pools and controls were utilized.

Samples were measured on ARCHITECT i2000SR (Abbott, Abbott Park, IL, USA) at three sites and Abbott’s Alinity i analyzer at one site using respective Tg and anti-Tg reagents, calibrators, and controls. For method comparison, samples were measured on a cobas 411 (Roche Diagnostics, Rotkreuz, Switzerland) at all three sites and on UniCel DxI 800 (Beckman Coulter, Brea, CA, USA) at one site using respective reagents, calibrators, and controls. Anti-Tg status was determined using Alinity i anti-Tg assay or ARCHITECT anti-Tg.

Serum Tg measured using with ARCHITECT was compared with the Roche Elecsys Tg II results. In total, 447 patient samples were analyzed for ARCHITECT and Roche with 56 samples positive for anti-Tg (cutoff 4.1 IU/mL). ARCHITECT Tg concentrations were ranging from 0.09 to 486 ng/mL for anti-Tg-negative and 0.09 to 341 ng/mL for anti-Tg-positive samples. Roche Tg values were closely correlated, with a correlation coefficient greater than 0.98 and a slope within 0.9–1.1 for anti-Tg-negative and anti-Tg-positive samples. Limit of quantitation (LoQ) was verified to be less than or equal to 0.1 ng/mL confirming that the Tg assay on ARCHITECT and Alinity was highly sensitive.

The authors concluded that the Abbott Thyroglobulin assay, which is standardized to the human thyroglobulin reference material (CRM-457), demonstrated a high correlation to the Roche and Beckman Tg assays, though good agreement of absolute values was only observed between Abbott and Roche. Strength of correlation and slope were not affected by the presence of anti-Tg indicating that all assays included in the study have a similar susceptibility to anti-Tg. The study was published on July 15, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
University Health Network 
Abbott
Roche Diagnostics 
Beckman Coulter 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
New
PBC Assay
Primary Biliary Cholangitis Assays
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: Early prediction of preterm birth in cell-free RNA could revolutionize prevention strategies (Photo courtesy of 123RF)

Blood Cell-Free RNA Signatures Can Predict Preterm Birth Four Months Before Delivery

Every year, around 13.4 million babies are born prematurely worldwide, accounting for roughly one in ten of all live births. Of these, nearly one million preterm infants die annually, and preterm birth... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.